Correlation analysis of serum Rac1 level with asthma control, airway inflammatory response and lung function in

Hui Fu1, Yun Gao2

  • 1Department of Pediatrics, The Third Affiliated Hospital of Nanjing Medical University, The Second People's Hospital of Changzhou, Changzhou, 213000, China.

BMC Pulmonary Medicine
|September 16, 2024
PubMed

Insights

Serum Rac1 mRNA levels are lower in children with asthma, correlating with poorer lung function and increased inflammation. Higher Rac1 levels indicate better asthma control and prognosis.

Area of Science:

  • Pediatric Pulmonology
  • Molecular Biology
  • Immunology

Background:

  • Asthma is a chronic respiratory disease affecting children worldwide.
  • Asthma control, airway inflammation, and lung function are key indicators of disease severity and prognosis.
  • Rac1, a Rho family GTPase, plays roles in cellular processes relevant to inflammation and immune responses.

Purpose of the Study:

  • To investigate the correlation between serum Rac1 enzyme (Rac1) levels and asthma control, airway inflammatory response, and lung function in asthmatic children.
  • To evaluate Rac1 as a potential biomarker for asthma severity and prognosis in pediatric patients.

Main Methods:

  • A retrospective analysis of 79 children with asthma, categorized by severity (mild, moderate, severe), compared to 36 healthy controls.
  • Serum Rac1 mRNA levels, inflammatory factors (TNF-α, IL-5, IL-6, IL-33), and lung function parameters (FVC, FEV1/FVC, PEF, MMEF) were measured and compared.
  • Statistical analysis was used to determine correlations between Rac1 levels, inflammatory markers, lung function, and disease control.

Main Results:

  • Asthmatic children exhibited significantly lower serum Rac1 mRNA levels, reduced lung function (FVC, FEV1/FVC, PEF, MMEF), and elevated inflammatory markers (TNF-α, IL-5, IL-6, IL-33) compared to controls.
  • Worsening asthma severity was associated with decreased Rac1 levels and lung function, and increased inflammation.
  • Improved asthma control correlated with increased Rac1 levels and lung function, and decreased inflammation.
  • Rac1 levels showed significant negative correlations with inflammatory markers and positive correlations with lung function parameters.
  • Rac1 mRNA levels, FVC, FEV1/FVC, PEF, and MMEF were identified as protective factors, while TNF-α, IL-5, IL-6, and IL-33 were risk factors for asthma prognosis.

Conclusions:

  • Children with asthma demonstrate lower serum Rac1 mRNA levels, heightened airway inflammation, and impaired lung function.
  • Serum Rac1 mRNA levels may serve as a valuable indicator for assessing asthma control, airway inflammation, lung function, and disease severity in children.
  • Rac1 has potential as a biomarker for evaluating the state of illness, treatment efficacy, and prognosis in pediatric asthma.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
371
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246